• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

家长对婴儿血管瘤美容临床结果的评估:西班牙全国血管瘤前瞻性队列研究结果

Parental Assessment of Infantile Hemangioma Cosmetic Clinical Outcomes: Results of the Spanish Hemangioma Nationwide Prospective Cohort.

作者信息

Colmenero-Sendra M, Del Boz-González J, Baselga Torres E, Bernabéu-Wittel J, Roé-Crespo E, Vicente A, Valdivieso-Ramos M, Martín-Santiago A, Palencia-Pérez S I, Montserrat-García M T, Azón-Masoliver A, Dañino M, Tubau Prims C, Prat C, Giacaman A, Domínguez-Cruz J J, Bauzá Alonso A, Grau-Pérez M, Descalzo M Á, García-Doval I

机构信息

Dermatology Department, Hospital Costa del Sol, Marbella, Spain; Programa de Doctorado en Medicina Clínica y Salud Pública, Universidad de Granada, Spain.

Dermatology Department, Hospital Regional Universitario de Málaga, Spain.

出版信息

Actas Dermosifiliogr. 2025 Apr;116(4):327-336. doi: 10.1016/j.ad.2024.06.010. Epub 2024 Jul 18.

DOI:10.1016/j.ad.2024.06.010
PMID:39032773
Abstract

BACKGROUND

Functional impairment is the main consideration when it comes to choosing therapy for infantile hemangiomas (IH). However, since most hemangiomas are treated for cosmetic reasons, it is important to know the cosmetic outcome assessed by the parents.

OBJECTIVE

To evaluate the aesthetic outcomes of IH, considering the characteristics of the lesions and the treatments used.

PATIENTS AND METHODS

The Spanish Infantile Hemangioma Nationwide Prospective Cohort (2016-2022) recruited all consecutive patients diagnosed with IH in 12 Spanish hospitals. The children included had two photos of the IH lesion (at both baseline and at the end of the study). A panel of parents blindly assessed all available photos using a scale from 0 (worst cosmetic outcomes) to 10 (best cosmetic outcomes). The different scores - both before and after treatment - as well as the outcomes percent considered excellent (>9) were described and compared. We analyzed the effect of receiving different therapies and performed causal model analyses estimating the mean treatment effect of parents' assessments.

RESULTS

The median follow-up was 3.1 years. A total of 824 photos were evaluated. Baseline aesthetic impact was higher in the propranolol group vs the topical timolol and observation treatment groups (1.85 vs 3.14 vs 3.66 respectively; p<0.001). After treatment, the aesthetic impact was similar between both treatment groups (7.59 vs 7.93 vs 7.90; p>0.2). The causal model could only be applied to the comparison between topical timolol and observation, revealing no differences whatsoever.

CONCLUSION

This is the first prospective cohort to analyze the aesthetic outcome of IH. The final aesthetic results of the three therapies were similar, with nearly 40% of patients achieving excellent aesthetic outcomes.

摘要

背景

在选择婴儿血管瘤(IH)的治疗方法时,功能损害是主要考虑因素。然而,由于大多数血管瘤是出于美容原因进行治疗的,了解家长评估的美容效果很重要。

目的

考虑病变特征和所用治疗方法,评估婴儿血管瘤的美学效果。

患者和方法

西班牙全国婴儿血管瘤前瞻性队列研究(2016 - 2022年)招募了西班牙12家医院中所有连续诊断为婴儿血管瘤的患者。纳入的儿童有两张婴儿血管瘤病变的照片(基线时和研究结束时)。一组家长使用从0(最差美容效果)到10(最佳美容效果)的量表对所有可用照片进行盲评。描述并比较了治疗前后的不同评分以及被认为优秀(>9)的结果百分比。我们分析了接受不同治疗的效果,并进行因果模型分析以估计家长评估的平均治疗效果。

结果

中位随访时间为3.1年。共评估了824张照片。普萘洛尔组的基线美学影响高于局部噻吗洛尔组和观察治疗组(分别为1.85、3.14和3.66;p<0.001)。治疗后,两个治疗组的美学影响相似(7.59、7.93和7.90;p>0.2)。因果模型仅适用于局部噻吗洛尔与观察治疗的比较,未发现任何差异。

结论

这是首个分析婴儿血管瘤美学效果的前瞻性队列研究。三种治疗方法的最终美学结果相似,近40%的患者获得了优秀的美学效果。

相似文献

1
Parental Assessment of Infantile Hemangioma Cosmetic Clinical Outcomes: Results of the Spanish Hemangioma Nationwide Prospective Cohort.家长对婴儿血管瘤美容临床结果的评估:西班牙全国血管瘤前瞻性队列研究结果
Actas Dermosifiliogr. 2025 Apr;116(4):327-336. doi: 10.1016/j.ad.2024.06.010. Epub 2024 Jul 18.
2
Interobserver and Intraobserver Agreement on the Treatment of Infantile Hemangiomas.婴儿血管瘤治疗的观察者间和观察者内一致性
JAMA Dermatol. 2025 Feb 1;161(2):203-207. doi: 10.1001/jamadermatol.2024.5125.
3
Interventions for infantile haemangiomas of the skin.皮肤婴儿血管瘤的干预措施。
Cochrane Database Syst Rev. 2018 Apr 18;4(4):CD006545. doi: 10.1002/14651858.CD006545.pub3.
4
The timing and safety of topical timolol treatment for superficial infantile hemangioma: a retrospective cohort study.噻吗洛尔局部治疗浅表性婴儿血管瘤的时机与安全性:一项回顾性队列研究
Eur J Pediatr. 2025 Jan 24;184(2):151. doi: 10.1007/s00431-025-05983-3.
5
Oral Propranolol With Topical Timolol Maleate Therapy for Mixed Infantile Hemangiomas in Oral and Maxillofacial Regions.口服普萘洛尔联合局部用马来酸噻吗洛尔治疗口腔颌面部混合型婴幼儿血管瘤
J Craniofac Surg. 2016 Jan;27(1):56-60. doi: 10.1097/SCS.0000000000002221.
6
Inter- and intra-observer variability in the selection of therapy for infantile hemangiomas among pediatric dermatologists in Spain.西班牙儿科皮肤科医生在婴儿血管瘤治疗选择中的组内和组间观察者变异性。
Pediatr Dermatol. 2022 Jul;39(4):557-562. doi: 10.1111/pde.15015. Epub 2022 May 3.
7
Efficacy and Safety of Topical Timolol for the Treatment of Infantile Hemangioma in the Early Proliferative Stage: A Randomized Clinical Trial.局部用噻吗洛尔治疗婴儿血管瘤早期增殖期的疗效和安全性:一项随机临床试验。
JAMA Dermatol. 2021 May 1;157(5):583-587. doi: 10.1001/jamadermatol.2021.0596.
8
Topical timolol maleate 0.5% for infantile hemangioma; it's effectiveness and/or adjunctive pulsed dye laser - single center experience of 102 cases in Korea.0.5%马来酸噻吗洛尔外用治疗婴幼儿血管瘤;其有效性及/或联合脉冲染料激光——韩国102例单中心经验
J Dermatolog Treat. 2015;26(4):389-91. doi: 10.3109/09546634.2014.990412. Epub 2014 Dec 29.
9
[A clinical study of Timolol Maleate Eye Drops for the treatment of superficial infantile hemangiomas].马来酸噻吗洛尔滴眼液治疗婴幼儿浅表性血管瘤的临床研究
Zhonghua Zheng Xing Wai Ke Za Zhi. 2015 Nov;31(6):440-5.
10
Application of color Doppler ultrasound in the treatment of infantile hemangioma by applying timolol combined with Cynergy dual-wavelength laser : Application of color Doppler ultrasound in the treatment of infantile hemangioma.彩色多普勒超声在噻吗洛尔联合Cynergy双波长激光治疗婴幼儿血管瘤中的应用:彩色多普勒超声在婴幼儿血管瘤治疗中的应用。
Lasers Med Sci. 2025 Feb 18;40(1):101. doi: 10.1007/s10103-025-04356-4.

引用本文的文献

1
Interobserver and Intraobserver Agreement on the Treatment of Infantile Hemangiomas.婴儿血管瘤治疗的观察者间和观察者内一致性
JAMA Dermatol. 2025 Feb 1;161(2):203-207. doi: 10.1001/jamadermatol.2024.5125.
2
Efficacy and safety of oral propranolol and topical timolol in the treatment of infantile hemangioma: a meta-analysis and systematic review.口服普萘洛尔和局部用噻吗洛尔治疗婴幼儿血管瘤的疗效与安全性:一项荟萃分析和系统评价
Front Pharmacol. 2024 Dec 2;15:1515901. doi: 10.3389/fphar.2024.1515901. eCollection 2024.